14.95
0.21 (1.42%)
| Previous Close | 14.74 |
| Open | 14.80 |
| Volume | 1,050,469 |
| Avg. Volume (3M) | 2,796,690 |
| Market Cap | 2,746,246,912 |
| Price / Earnings (TTM) | 8.08 |
| Price / Earnings (Forward) | 8.28 |
| Price / Sales | 6.42 |
| Price / Book | 1.24 |
| 52 Weeks Range | |
| Earnings Date | 30 Apr 2026 |
| TTM Dividend Yield | 10.50% |
| Profit Margin | 45.23% |
| Operating Margin (TTM) | 83.30% |
| Diluted EPS (TTM) | 1.33 |
| Quarterly Revenue Growth (YOY) | -1.70% |
| Quarterly Earnings Growth (YOY) | -44.70% |
| Total Debt/Equity (MRQ) | 99.66% |
| Current Ratio (MRQ) | 0.340 |
| Operating Cash Flow (TTM) | -99.39 M |
| Levered Free Cash Flow (TTM) | 235.30 M |
| Return on Assets (TTM) | 6.67% |
| Return on Equity (TTM) | 11.44% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Asset Management (US) | Bearish | Bearish |
| Asset Management (Global) | Bearish | Bearish | |
| Stock | Hercules Capital, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | 1.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 1.75 |
|
Hercules Capital Inc is a specialty finance company that provides senior secured loans to high-growth, venture capital-backed companies in various technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries, including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology. |
|
| Sector | Financial Services |
| Industry | Asset Management |
| Investment Style | Small Value |
| % Held by Insiders | 1.83% |
| % Held by Institutions | 24.92% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Advisors Capital Management, Llc | 31 Dec 2025 | 828,258 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 19.00 (Keefe, Bruyette & Woods, 27.09%) | Buy |
| Median | 17.50 (17.06%) | |
| Low | 17.00 (Wells Fargo, 13.71%) | Buy |
| Average | 17.83 (19.26%) | |
| Total | 2 Buy, 1 Hold | |
| Avg. Price @ Call | 15.58 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Keefe, Bruyette & Woods | 13 Feb 2026 | 19.00 (27.09%) | Buy | 15.58 |
| Piper Sandler | 13 Feb 2026 | 17.50 (17.06%) | Hold | 15.58 |
| Wells Fargo | 13 Feb 2026 | 17.00 (13.71%) | Buy | 15.58 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 29 Jan 2026 | Announcement | Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2025 Financial Results and Conference Call |
| 27 Jan 2026 | Announcement | Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI* |
| 20 Jan 2026 | Announcement | enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc. |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |